Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
113.00    1.50 (1.35%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £67.98m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

7 Oct 2015 07:00

RNS Number : 4549B
Intercede Group PLC
07 October 2015
 

7 October 2015

Intercede Group plc

 

("Intercede" or the "Company")

 

Trading Update

 

We are pleased to report that Intercede has achieved strong revenue growth during the first half of the financial year. This is in line with expectations and reflects continued progress with existing customers and a number of new contract wins.

 

First half revenues increased by more than 35% compared to the previous year from £4.0 million to approximately £5.5 million. An enlarged sales and marketing team continues to drive business expansion and during the period we have secured an enterprise-wide contract with one of the largest US healthcare corporations, sold our mobile derived credential solution to a major US Federal Agency, signed a new agreement with a US West Coast bank and made our first sale following the announcement of the Partner Agreement with Citrix on 13 May 2015.

 

As previously announced, we continue to invest in the recruitment and training of specialist technical professionals to ensure we remain scalable in a fast growing market. The size of the team has grown by approaching 10% year on year.

 

The new contracts will all yield further revenues during the current year and beyond. The strong start to the year provides a solid base to meet market expectations for the year.

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

finnCap

Tel. + 44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Joanna Weaving, Corporate Broking

 

About Intercede

Intercede is a software and service company specialising in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity.

Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years.

Intercede's MyID software is an identity and credential management system that enables organisations to create and assign trusted digital identities to employees, citizens and machines and in turn allows secure access to services, facilities, information and networks. MyID adheres to international standards, while remaining simple enough to be deployed onto consumer devices such as smartphones, tablets and other devices in the Internet of Things.

In 2015 Intercede launched MyTAM; enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. The cloud-based service provides a cost-effective and convenient way for developers and corporations to protect their apps and users' sensitive data.

For more information visit: www.intercede.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSWFWMFISEFS
Date   Source Headline
5th Jan 20177:00 amRNSReceipt of $3.0m Order
28th Dec 20167:00 amRNSDirectorate Change
28th Dec 20167:00 amRNSHalf-year Report
28th Dec 20167:00 amRNSProposed Fundraising
16th Sep 20162:15 pmRNSDirector/PDMR Shareholding
16th Sep 20167:00 amRNSTrading Update
14th Sep 20163:52 pmRNSResult of AGM
1st Aug 20167:00 amRNSIssue of Equity & Share Incentive Plan
7th Jun 20167:00 amRNSFinal Results
18th May 20167:00 amRNSShare Incentive Plan
7th Apr 20167:00 amRNSYear End Trading Update
21st Mar 20161:21 pmRNSShare Incentive Plan
1st Mar 20162:00 pmRNSMyID within Intel Authenticate
22nd Feb 20167:00 amRNSNew Android Security Platform
7th Jan 20163:28 pmRNSTransaction in Own Shares
3rd Nov 20157:00 amRNSHalf Yearly Report
7th Oct 20157:00 amRNSTrading Update
16th Sep 20154:40 pmRNSResult of AGM
2nd Sep 20152:53 pmRNSShare Award
30th Jul 20153:37 pmRNSShare Incentive Plan
6th Jul 20157:00 amRNSTrading Update
2nd Jun 20157:00 amRNSFinal Results
28th May 20157:00 amRNSIntercede & Good to deliver secure mobility
19th May 20157:00 amRNSNew Partner for Intercede's MyTAM Service
14th May 20157:00 amRNSShare Incentive Plan
13th May 20157:00 amRNSIntercede & Citrix to deliver secure mobility
21st Apr 20157:00 amRNSNew Partner for Intercede's MyTAM Service
2nd Apr 201512:00 pmRNSTrading Update
18th Mar 20157:00 amRNSShare Incentive Plan
16th Mar 20157:00 amRNSAppointment of Non-Executive Director
26th Feb 20157:01 amRNSNew Partner for Intercede's MyTAM Service
25th Feb 20157:02 amRNSNew Partner for Intercede's MyTAM Service
17th Feb 201511:00 amRNSLaunch of MyTAM - a fully hosted cloud service
5th Feb 20159:00 amRNSTransaction in Own Shares
3rd Feb 20157:00 amRNSTransaction in Own Shares
26th Jan 201510:19 amRNSDirector Share Dealings & Resignation
21st Jan 20157:00 amRNSTrading Statement
15th Jan 20157:00 amRNSTransaction in Own Shares
23rd Dec 20144:10 pmRNSTransaction in Own Shares
22nd Dec 20147:00 amRNSTransaction in Own Shares
19th Dec 201412:35 pmRNSExercise of Options and Total Voting Rights
19th Dec 20147:00 amRNSTransaction in Own Shares
18th Dec 20147:00 amRNSTransaction in Own Shares
17th Dec 20147:00 amRNSTransaction in Own Shares
15th Dec 20147:00 amRNSTransaction in Own Shares
12th Dec 20147:00 amRNSTransaction in Own Shares
5th Dec 20147:00 amRNSTransaction in Own Shares
3rd Dec 20147:00 amRNSTransaction in Own Shares
1st Dec 20147:00 amRNSTransaction in Own Shares
10th Nov 20149:28 amRNSDirector and PDMR Share Option Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.